These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31018803)

  • 1. Dimethyltryptamine: Endogenous Role and Therapeutic Potential.
    Rodrigues AV; Almeida FJ; Vieira-Coelho MA
    J Psychoactive Drugs; 2019; 51(4):299-310. PubMed ID: 31018803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basics of the medical use of ayahuasca: physiology of dimethyltryptamine.
    Ede F; Attila K; Attila S; Csaba F; Csaba M
    Lege Artis Med; 2016; 26(9-10):413. PubMed ID: 29537778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.
    Shinozuka K; Tabaac BJ; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e112-e120. PubMed ID: 38518268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).
    Cameron LP; Olson DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2344-2357. PubMed ID: 30036036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ayahuasca - potential therapeutic properties in psychiatry. Research review.
    Barabasz-Gembczyk A; Kucia K
    Psychiatr Pol; 2020 Apr; 54(2):381-389. PubMed ID: 32772067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.
    James E; Keppler J; L Robertshaw T; Sessa B
    Hum Psychopharmacol; 2022 May; 37(3):e2835. PubMed ID: 35175662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ayahuasca for the Treatment of Depression.
    Palhano-Fontes F; Soares BL; Galvão-Coelho NL; Arcoverde E; Araujo DB
    Curr Top Behav Neurosci; 2022; 56():113-124. PubMed ID: 34761362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
    Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelics and Personality.
    Aixalà M; Dos Santos RG; Hallak JEC; Bouso JC
    ACS Chem Neurosci; 2018 Oct; 9(10):2304-2306. PubMed ID: 29863323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
    Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
    Gable RS
    Addiction; 2007 Jan; 102(1):24-34. PubMed ID: 17207120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological interaction of compounds in ayahuasca: a systematic review.
    Ruffell S; Netzband N; Bird C; Young AH; Juruena MF
    Braz J Psychiatry; 2020; 42(6):646-656. PubMed ID: 32638916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.
    Nunes AA; Dos Santos RG; Osório FL; Sanches RF; Crippa JA; Hallak JE
    J Psychoactive Drugs; 2016; 48(3):195-205. PubMed ID: 27230395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.
    Egger K; Aicher HD; Cumming P; Scheidegger M
    Cell Mol Life Sci; 2024 Sep; 81(1):395. PubMed ID: 39254764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ayahuasca and the traveller: A scoping review of risks and possible benefits.
    Houle SKD; Evans D; Carter CA; Schlagenhauf P
    Travel Med Infect Dis; 2021; 44():102206. PubMed ID: 34785376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ayahuasca: What Healthcare Providers Need to Know.
    Goldin D; Salani D
    J Addict Nurs; 2021 Apr-Jun 01; 32(2):167-173. PubMed ID: 34060770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
    Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
    Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT.
    Barker SA
    Psychopharmacology (Berl); 2022 Jun; 239(6):1749-1763. PubMed ID: 35064294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.
    Rossi GN; Guerra LTL; Baker GB; Dursun SM; Saiz JCB; Hallak JEC; Dos Santos RG
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.